Pronexus Analytical

Pronexus Analytical is a specialized preclinical contract research organization (CRO) based in Sweden, focused on the pharmacology and neurochemistry of the central nervous system (CNS). Founded in 2003 by pioneers of the microdialysis technique from the Karolinska Institutet, the company provides advanced in vivo and bioanalytical services to support drug discovery and development. Their core expertise includes high-sensitivity neurochemical analysis, PK/PD studies, and the use of experimental models for various CNS disorders such as Parkinson's and Alzheimer's disease. Pronexus operates under GLP-compliant conditions and collaborates with global pharmaceutical and biotech partners to provide critical data on drug-target interactions and neurotransmitter dynamics. The company is recognized for its ability to monitor real-time chemical signaling in the brain using microdialysis and biosensor technologies.